- Home
- Automated
- NDF A-Z listing
- Pneumococcal Conjugate Vaccine [15-valent]
P
Pneumococcal Conjugate Vaccine [15-valent]
Subsidy Information and Financing Scheme
No
Drug Guidance
Yes
Post-marketing information
No
Summary of Biologics
No
Active ingredients: Vaccine Pneumococcal | Pneumococcal Vaccine | Pneumococcal Conjugate Vaccine [15-valent]
General information
Subsidy Information and Financing Scheme
Not Applicable
Drug Guidance for Subsidy
The Ministry of Health’s Drug Advisory Committee has recommended:
Pneumococcal conjugate vaccine 20-valent (PCV20) 0.5 mL suspension for injection in pre-filled syringe for active immunisation for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae for all adults aged 65 years and older, and other adults aged 18 to 64 years who are at increased risk for pneumococcal disease.
Funding status
[R] PCV20 0.5 mL suspension for injection in pre-filled syringe is recommended for inclusion on the MOH Subsidised Vaccine List (SVL) for the abovementioned indication from September 2025.
[NR] Subsidy does not apply to pneumococcal conjugate vaccine 15-valent (PCV15).
Legend
This section displays recommendation from the MOH Drug Advisory Committee for subsidy and appropriate use of the drug as extracted from the Agency for Care Effectiveness (ACE) Drug Guidances. As this website is updated monthly, please refer to the ACE website for the most updated information.
Legend list
Indicator | Legend |
|---|---|
R | Recommended for subsidy |
NR | Not recommended for subsidy |